SWX:MOLN.SW

Molecular Partners Stock Pops Into Holiday Pause as Traders Eye Cancer-Drug Data
····

Molecular Partners Stock Pops Into Holiday Pause as Traders Eye Cancer-Drug Data

Molecular Partners shares closed at CHF 3.15 on Friday, up 9.38%, ahead of a market pause for Whit Monday and Memorial Day. The company will present first-in-human data for its lead Radio-DARPin candidate MP0712 at a Basel meeting on May 29. Q1 filings showed no revenue, R&D costs of CHF 9.45 million, and a net loss of CHF 13.14 million. Cash reserves stood at CHF 79 million at March-end.
May 25, 2026

Stock Market Today

  • ASX Investors Face Hidden Overexposure to US 'Magnificent 7' Tech Giants
    May 29, 2026, 8:06 PM EDT. Many Australian investors may unknowingly hold significant stakes in the US tech giants known as the 'Magnificent 7'-Microsoft, Amazon, Alphabet, Meta Platforms, Apple, Tesla, and NVIDIA. These companies dominate various US exchange-traded funds (ETFs) like BetaShares Nasdaq 100 (NDQ), Schwab U.S. Large-Cap Growth (SCHG), iShares S&P 500 (IVV), and others widely held in Australia. In addition, large positions in listed investment companies (LICs) such as MFF Capital and ETFs like VanEck Morningstar Wide Moat (MOAT) further increase exposure. Superannuation funds also typically include these stocks, amplifying collective investment risk. Investors should audit their portfolios to understand the extent of their indirect and direct holdings in these tech behemoths amid their growing market dominance.